European Journal of Clinical Investigation

Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease
pp. 537-545(9)
Authors: Wu, T. C.; Leu, H. B.; Lin, W. T.; Lin, C. P.; Lin, S. J.; Chen, J. W.

Ischaemia or reperfusion: which is a main trigger for changes in nitric oxide mRNA synthases expression?
pp. 546-550(5)
Authors: Pevni, D.; Frolkis, I.; Shapira, I.; Schwartz, D.; Schwartz, I. F.; Chernichovski, T.; Lev-Ran, O.; Sharony, R.; Uretzky, G.

Reduction of postchallenge hyperglycaemia prevents acute endothelial dysfunction in subjects with impaired glucose tolerance
pp. 551-557(7)
Authors: Wascher, T. C.; Schmoelzer, I.; Wiegratz, A.; Stuehlinger, M.; Mueller-Wieland, D.; Kotzka, J.; Enderle, M.

Effect of rosuvastatin on insulin sensitivity in patients with familial combined hyperlipidaemia
pp. 558-564(7)
Authors: ter Avest, E.; Abbink, E. J.; de Graaf, J.; Tack, C. J.; Stalenhoef, A. F. H.

Glucagon-like peptide-1 reduces the pulsatile component of testosterone secretion in healthy males
pp. 565-572(8)
Authors: Jeibmann, A.; Zahedi, S.; Simoni, M.; Nieschlag, E.; Byrne, M. M.

Azithromycin reduces Chlamydia pneumoniae-induced attenuation of eNOS and cGMP production by endothelial cells
pp. 573-582(10)
Authors: Bouwman, J. J. M.; Visseren, F. L. J.; Bevers, L. M.; van der Vlist, W. E.; Bouter, K. P.; Diepersloot, R. J. A.

Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines
pp. 583-590(8)
Authors: He, G.; Andersen, O.; Haugaard, S. B.; Lihn, A. S.; Pedersen, S. B.; Madsbad, S.; Richelsen, B.

Morin sulphates/glucuronides enhance macrophage function in microgravity culture system
pp. 591-596(6)
Authors: Hsieh, C.-L.; Chao, P.-D. L.; Fang, S.-H.

The ESCI Award for Excellence in Clinical Science
pp. 597-597(1)